OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
86 hedge funds and large institutions have $123M invested in OncoMed Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
35% less capital invested
Capital invested by funds: $189M → $123M (-$65.9M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
86
Holding in Top 10
1
Calls
$1.06M
Puts
$465K
Top Buyers
| 1 | +$3.84M | |
| 2 | +$1.68M | |
| 3 | +$954K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$708K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$679K |
Top Sellers
| 1 | -$6.94M | |
| 2 | -$3.04M | |
| 3 | -$2.59M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.4M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$972K |